Literature DB >> 12699294

Biochemical markers of bone remodeling.

Markus J Seibel1.   

Abstract

Because of the aging population in most countries, disorders of bone and mineral metabolism are becoming increasingly relevant to everyday clinical practice. Consequently, the interest in, and the need for effective measures to be used in the screening, diagnosis, and follow-up of such pathologies has markedly grown. Together with clinical and imaging techniques, laboratory tests play an important role in the assessment and differential diagnosis of metabolic bone disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12699294     DOI: 10.1016/s0889-8529(02)00077-4

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  15 in total

Review 1.  Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.

Authors:  Serge Cremers; Patrick Garnero
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Effects of resistance training on biomarkers of bone formation and association with red blood cell variables.

Authors:  Min Hu; Taija Finni; Leiting Xu; Liangchou Zou; Sulin Cheng
Journal:  J Physiol Biochem       Date:  2011-03-11       Impact factor: 4.158

3.  Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study.

Authors:  Stine Marit Moen; Elisabeth Gulowsen Celius; Leiv Sandvik; Magritt Brustad; Lars Nordsletten; Erik Fink Eriksen; Trygve Holmøy
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

4.  Cathepsin K in treatment monitoring following intravenous zoledronic acid.

Authors:  Oliver Jahn; Thomas Wex; Silke Klose; Siegfried Kropf; Daniela Adolf; Stefan Piatek
Journal:  Biomed Rep       Date:  2014-09-10

5.  Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: a consensus advice from an Austrian working group.

Authors:  Christian Bieglmayer; Hans Peter Dimai; Rudolf Wolfgang Gasser; Stefan Kudlacek; Barbara Obermayer-Pietsch; Wolfgang Woloszczuk; Elisabeth Zwettler; Andrea Griesmacher
Journal:  Wien Med Wochenschr       Date:  2012-08-14

6.  Estimation of serum osteocalcin and telopeptide-C in postmenopausal osteoporotic females.

Authors:  M Lateef; M Baig; A Azhar
Journal:  Osteoporos Int       Date:  2009-07-14       Impact factor: 4.507

Review 7.  Chronic kidney disease and bone fracture: a growing concern.

Authors:  Thomas L Nickolas; Mary B Leonard; Elizabeth Shane
Journal:  Kidney Int       Date:  2008-06-18       Impact factor: 10.612

Review 8.  Pediatric vitamin D and calcium nutrition in developing countries.

Authors:  Philip R Fischer; Tom D Thacher; John M Pettifor
Journal:  Rev Endocr Metab Disord       Date:  2008-07-06       Impact factor: 9.306

9.  The effect of oxandrolone treatment on human osteoblastic cells.

Authors:  Lian Xiang Bi; Kristine M Wiren; Xiao-Wei Zhang; Gisele V Oliveira; Gordon L Klein; Elgene G Mainous; David N Herndon
Journal:  J Burns Wounds       Date:  2007-03-07

10.  The effect of metyrosine/prednisolone combination to oophorectomy-induced osteoporosis.

Authors:  Suleyman Salman; Serkan Kumbasar; Ahmet Hacimuftuoglu; Berna Ozturk; Bedri Seven; Beyzagul Polat; Cemal Gundogdu; Elif Demirci; Kadir Yildirim; Fatih Akcay; Turan Uslu; Ferrah Tuncel Daloglu; Halis Suleyman
Journal:  Iran J Reprod Med       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.